Literature DB >> 26854023

A Binding Site on IL-17A for Inhibitory Macrocycles Revealed by Hydrogen/Deuterium Exchange Mass Spectrometry.

Alfonso Espada1, Howard Broughton1, Spencer Jones2, Michael J Chalmers2, Jeffrey A Dodge2.   

Abstract

Computational assessment of the IL-17A structure identified two distinct binding pockets, the β-hairpin pocket and the α-helix pocket. The β-hairpin pocket was hypothesized to be the site of binding for peptide macrocycles. Support for this hypothesis was obtained using HDX-MS which revealed protection to exchange only within the β-hairpin pocket. This data represents the first direct structural evidence of a small molecule binding site on IL-17A that functions to disrupt the interaction with its receptor.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26854023     DOI： 10.1021/acs.jmedchem.5b01693

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


  6 in total

1.  Deciphering Binding Interactions of IL-23R with HDX-MS: Mapping Protein and Macrocyclic Dodecapeptide Ligands.

Authors:  Cristina Sayago; Isabel C Gonzalez Valcarcel; Yuewei Qian; John Lee; Jorge Alsina-Fernandez; Nathan C Fite; Juan J Carrillo; Feiyu F Zhang; Michael J Chalmers; Jeffrey A Dodge; Howard Broughton; Alfonso Espada
Journal:  ACS Med Chem Lett       Date:  2018-08-01       Impact factor: 4.345

2.  A Decoupled Automation Platform for Hydrogen/Deuterium Exchange Mass Spectrometry Experiments.

Authors:  Alfonso Espada; Ruben Haro; Jesus Castañon; Cristina Sayago; Francisco Perez-Cozar; Leticia Cano; Pablo Redero; Manuel Molina-Martin; Howard Broughton; Ryan E Stites; Bruce D Pascal; Patrick R Griffin; Jeffrey A Dodge; Michael J Chalmers
Journal:  J Am Soc Mass Spectrom       Date:  2019-11-13       Impact factor: 3.109

3.  Artificial Macrocycles as IL-17A/IL-17RA Antagonists.

Authors:  Wenjia Wang; Matthew R Groves; Alexander Dömling
Journal:  Medchemcomm       Date:  2017-10-25       Impact factor: 3.597

4.  Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery.

Authors:  Joey P Ting; Frances Tung; Stephen Antonysamy; Stephen Wasserman; Spencer B Jones; Feiyu F Zhang; Alfonso Espada; Howard Broughton; Michael J Chalmers; Michael E Woodman; Holly A Bina; Jeffrey A Dodge; Jordi Benach; Aiping Zhang; Christopher Groshong; Danalyn Manglicmot; Marijane Russell; Sepideh Afshar
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

Review 5.  Pharmacological Rationale for Targeting IL-17 in Asthma.

Authors:  Siti Farah Rahmawati; Maurice Te Velde; Huib A M Kerstjens; Alexander S S Dömling; Matthew Robert Groves; Reinoud Gosens
Journal:  Front Allergy       Date:  2021-08-30

6.  Multicomponent Macrocyclic IL-17a Modifier.

Authors:  Eman Abdelraheem; Max Lubberink; Wenja Wang; Jingyao Li; Atilio Reyes Romero; Robin van der Straat; Xiaochen Du; Matthew Groves; Alexander Dömling
Journal:  ACS Med Chem Lett       Date:  2022-08-12       Impact factor: 4.632
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.